N-アリルアミンのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global N-Allylamine (CAS 589-09-3) Market Insights and Forecast to 2027

• レポートコード：QY2112C00548 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はN-アリルアミンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。N-アリルアミンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（≥99％、≥98％、≥95％）、用途別市場規模（医薬品、コーティング、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・N-アリルアミンの世界市場概要 ・メーカー別の競争状況、市場シェア ・N-アリルアミンの種類別市場規模：≥99％、≥98％、≥95％ ・N-アリルアミンの用途別市場規模：医薬品、コーティング、その他 ・北米のN-アリルアミン市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのN-アリルアミン市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのN-アリルアミン市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のN-アリルアミン市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのN-アリルアミン市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Ningbo Jinlai Chemical Co., Ltd.、TimTec Corporation、Wuhan Fengyao Tonghui Chemical Products Co., Ltd.、Boc Sciences、City Chemical、Fluorochem、3B Scientific Corporation、Leancare Ltd、Hubei Xinrunde Chemical Co., Ltd.、Hubei Shishun Biological Technology Co., Ltd. ・N-アリルアミンのバリューチェーン・販売チャネル分析 ・N-アリルアミンの世界市場動向

N-Allylamine is a colorless liquid, used in the manufacture of pharmaceutical intermediates, as well as intermediates for agricultural chemicals, dyes and coatings, organic synthesis and resin modifiers.

Market Analysis and Insights: Global N-Allylamine (CAS 589-09-3) Market
The global N-Allylamine (CAS 589-09-3) market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global N-Allylamine (CAS 589-09-3) Scope and Segment
N-Allylamine (CAS 589-09-3) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global N-Allylamine (CAS 589-09-3) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
≥99%
≥98%
≥95%

Segment by Application
Medicine
Coating
Others

By Company
Ningbo Jinlai Chemical Co., Ltd.
TimTec Corporation
Wuhan Fengyao Tonghui Chemical Products Co., Ltd.
Boc Sciences
City Chemical
Fluorochem
3B Scientific Corporation
Leancare Ltd
Hubei Xinrunde Chemical Co., Ltd.
Hubei Shishun Biological Technology Co., Ltd.

Production by Region
North America
Europe
China
Japan

Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 N-Allylamine (CAS 589-09-3) Product Introduction
1.2 Market by Type
1.2.1 Global N-Allylamine (CAS 589-09-3) Market Size Growth Rate by Type
1.2.2 ≥99%
1.2.3 ≥98%
1.2.4 ≥95%
1.3 Market by Application
1.3.1 Global N-Allylamine (CAS 589-09-3) Market Size Growth Rate by Application
1.3.2 Medicine
1.3.3 Coating
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global N-Allylamine (CAS 589-09-3) Production
2.1 Global N-Allylamine (CAS 589-09-3) Production Capacity (2016-2027)
2.2 Global N-Allylamine (CAS 589-09-3) Production by Region: 2016 VS 2021 VS 2027
2.3 Global N-Allylamine (CAS 589-09-3) Production by Region
2.3.1 Global N-Allylamine (CAS 589-09-3) Historic Production by Region (2016-2021)
2.3.2 Global N-Allylamine (CAS 589-09-3) Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan

3 Global N-Allylamine (CAS 589-09-3) Sales in Volume & Value Estimates and Forecasts
3.1 Global N-Allylamine (CAS 589-09-3) Sales Estimates and Forecasts 2016-2027
3.2 Global N-Allylamine (CAS 589-09-3) Revenue Estimates and Forecasts 2016-2027
3.3 Global N-Allylamine (CAS 589-09-3) Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top N-Allylamine (CAS 589-09-3) Regions by Sales
3.4.1 Global Top N-Allylamine (CAS 589-09-3) Regions by Sales (2016-2021)
3.4.2 Global Top N-Allylamine (CAS 589-09-3) Regions by Sales (2022-2027)
3.5 Global Top N-Allylamine (CAS 589-09-3) Regions by Revenue
3.5.1 Global Top N-Allylamine (CAS 589-09-3) Regions by Revenue (2016-2021)
3.5.2 Global Top N-Allylamine (CAS 589-09-3) Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa

4 Competition by Manufactures
4.1 Global N-Allylamine (CAS 589-09-3) Production Capacity by Manufacturers
4.2 Global N-Allylamine (CAS 589-09-3) Sales by Manufacturers
4.2.1 Global Top N-Allylamine (CAS 589-09-3) Manufacturers by Sales (2016-2021)
4.2.2 Global Top N-Allylamine (CAS 589-09-3) Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by N-Allylamine (CAS 589-09-3) Sales in 2020
4.3 Global N-Allylamine (CAS 589-09-3) Revenue by Manufacturers
4.3.1 Global Top N-Allylamine (CAS 589-09-3) Manufacturers by Revenue (2016-2021)
4.3.2 Global Top N-Allylamine (CAS 589-09-3) Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by N-Allylamine (CAS 589-09-3) Revenue in 2020
4.4 Global N-Allylamine (CAS 589-09-3) Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global N-Allylamine (CAS 589-09-3) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global N-Allylamine (CAS 589-09-3) Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type
5.1 Global N-Allylamine (CAS 589-09-3) Sales by Type
5.1.1 Global N-Allylamine (CAS 589-09-3) Historical Sales by Type (2016-2021)
5.1.2 Global N-Allylamine (CAS 589-09-3) Forecasted Sales by Type (2022-2027)
5.1.3 Global N-Allylamine (CAS 589-09-3) Sales Market Share by Type (2016-2027)
5.2 Global N-Allylamine (CAS 589-09-3) Revenue by Type
5.2.1 Global N-Allylamine (CAS 589-09-3) Historical Revenue by Type (2016-2021)
5.2.2 Global N-Allylamine (CAS 589-09-3) Forecasted Revenue by Type (2022-2027)
5.2.3 Global N-Allylamine (CAS 589-09-3) Revenue Market Share by Type (2016-2027)
5.3 Global N-Allylamine (CAS 589-09-3) Price by Type
5.3.1 Global N-Allylamine (CAS 589-09-3) Price by Type (2016-2021)
5.3.2 Global N-Allylamine (CAS 589-09-3) Price Forecast by Type (2022-2027)

6 Market Size by Application
6.1 Global N-Allylamine (CAS 589-09-3) Sales by Application
6.1.1 Global N-Allylamine (CAS 589-09-3) Historical Sales by Application (2016-2021)
6.1.2 Global N-Allylamine (CAS 589-09-3) Forecasted Sales by Application (2022-2027)
6.1.3 Global N-Allylamine (CAS 589-09-3) Sales Market Share by Application (2016-2027)
6.2 Global N-Allylamine (CAS 589-09-3) Revenue by Application
6.2.1 Global N-Allylamine (CAS 589-09-3) Historical Revenue by Application (2016-2021)
6.2.2 Global N-Allylamine (CAS 589-09-3) Forecasted Revenue by Application (2022-2027)
6.2.3 Global N-Allylamine (CAS 589-09-3) Revenue Market Share by Application (2016-2027)
6.3 Global N-Allylamine (CAS 589-09-3) Price by Application
6.3.1 Global N-Allylamine (CAS 589-09-3) Price by Application (2016-2021)
6.3.2 Global N-Allylamine (CAS 589-09-3) Price Forecast by Application (2022-2027)

7 North America
7.1 North America N-Allylamine (CAS 589-09-3) Market Size by Type
7.1.1 North America N-Allylamine (CAS 589-09-3) Sales by Type (2016-2027)
7.1.2 North America N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2027)
7.2 North America N-Allylamine (CAS 589-09-3) Market Size by Application
7.2.1 North America N-Allylamine (CAS 589-09-3) Sales by Application (2016-2027)
7.2.2 North America N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2027)
7.3 North America N-Allylamine (CAS 589-09-3) Sales by Country
7.3.1 North America N-Allylamine (CAS 589-09-3) Sales by Country (2016-2027)
7.3.2 North America N-Allylamine (CAS 589-09-3) Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada

8 Europe
8.1 Europe N-Allylamine (CAS 589-09-3) Market Size by Type
8.1.1 Europe N-Allylamine (CAS 589-09-3) Sales by Type (2016-2027)
8.1.2 Europe N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2027)
8.2 Europe N-Allylamine (CAS 589-09-3) Market Size by Application
8.2.1 Europe N-Allylamine (CAS 589-09-3) Sales by Application (2016-2027)
8.2.2 Europe N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2027)
8.3 Europe N-Allylamine (CAS 589-09-3) Sales by Country
8.3.1 Europe N-Allylamine (CAS 589-09-3) Sales by Country (2016-2027)
8.3.2 Europe N-Allylamine (CAS 589-09-3) Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia

9 Asia Pacific
9.1 Asia Pacific N-Allylamine (CAS 589-09-3) Market Size by Type
9.1.1 Asia Pacific N-Allylamine (CAS 589-09-3) Sales by Type (2016-2027)
9.1.2 Asia Pacific N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2027)
9.2 Asia Pacific N-Allylamine (CAS 589-09-3) Market Size by Application
9.2.1 Asia Pacific N-Allylamine (CAS 589-09-3) Sales by Application (2016-2027)
9.2.2 Asia Pacific N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2027)
9.3 Asia Pacific N-Allylamine (CAS 589-09-3) Sales by Region
9.3.1 Asia Pacific N-Allylamine (CAS 589-09-3) Sales by Region (2016-2027)
9.3.2 Asia Pacific N-Allylamine (CAS 589-09-3) Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia

10 Latin America
10.1 Latin America N-Allylamine (CAS 589-09-3) Market Size by Type
10.1.1 Latin America N-Allylamine (CAS 589-09-3) Sales by Type (2016-2027)
10.1.2 Latin America N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2027)
10.2 Latin America N-Allylamine (CAS 589-09-3) Market Size by Application
10.2.1 Latin America N-Allylamine (CAS 589-09-3) Sales by Application (2016-2027)
10.2.2 Latin America N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2027)
10.3 Latin America N-Allylamine (CAS 589-09-3) Sales by Country
10.3.1 Latin America N-Allylamine (CAS 589-09-3) Sales by Country (2016-2027)
10.3.2 Latin America N-Allylamine (CAS 589-09-3) Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia

11 Middle East and Africa
11.1 Middle East and Africa N-Allylamine (CAS 589-09-3) Market Size by Type
11.1.1 Middle East and Africa N-Allylamine (CAS 589-09-3) Sales by Type (2016-2027)
11.1.2 Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2027)
11.2 Middle East and Africa N-Allylamine (CAS 589-09-3) Market Size by Application
11.2.1 Middle East and Africa N-Allylamine (CAS 589-09-3) Sales by Application (2016-2027)
11.2.2 Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2027)
11.3 Middle East and Africa N-Allylamine (CAS 589-09-3) Sales by Country
11.3.1 Middle East and Africa N-Allylamine (CAS 589-09-3) Sales by Country (2016-2027)
11.3.2 Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE

12 Corporate Profiles
12.1 Ningbo Jinlai Chemical Co., Ltd.
12.1.1 Ningbo Jinlai Chemical Co., Ltd. Corporation Information
12.1.2 Ningbo Jinlai Chemical Co., Ltd. Overview
12.1.3 Ningbo Jinlai Chemical Co., Ltd. N-Allylamine (CAS 589-09-3) Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Ningbo Jinlai Chemical Co., Ltd. N-Allylamine (CAS 589-09-3) Product Description
12.1.5 Ningbo Jinlai Chemical Co., Ltd. Recent Developments
12.2 TimTec Corporation
12.2.1 TimTec Corporation Corporation Information
12.2.2 TimTec Corporation Overview
12.2.3 TimTec Corporation N-Allylamine (CAS 589-09-3) Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 TimTec Corporation N-Allylamine (CAS 589-09-3) Product Description
12.2.5 TimTec Corporation Recent Developments
12.3 Wuhan Fengyao Tonghui Chemical Products Co., Ltd.
12.3.1 Wuhan Fengyao Tonghui Chemical Products Co., Ltd. Corporation Information
12.3.2 Wuhan Fengyao Tonghui Chemical Products Co., Ltd. Overview
12.3.3 Wuhan Fengyao Tonghui Chemical Products Co., Ltd. N-Allylamine (CAS 589-09-3) Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Wuhan Fengyao Tonghui Chemical Products Co., Ltd. N-Allylamine (CAS 589-09-3) Product Description
12.3.5 Wuhan Fengyao Tonghui Chemical Products Co., Ltd. Recent Developments
12.4 Boc Sciences
12.4.1 Boc Sciences Corporation Information
12.4.2 Boc Sciences Overview
12.4.3 Boc Sciences N-Allylamine (CAS 589-09-3) Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 Boc Sciences N-Allylamine (CAS 589-09-3) Product Description
12.4.5 Boc Sciences Recent Developments
12.5 City Chemical
12.5.1 City Chemical Corporation Information
12.5.2 City Chemical Overview
12.5.3 City Chemical N-Allylamine (CAS 589-09-3) Sales, Price, Revenue and Gross Margin (2016-2021)
12.5.4 City Chemical N-Allylamine (CAS 589-09-3) Product Description
12.5.5 City Chemical Recent Developments
12.6 Fluorochem
12.6.1 Fluorochem Corporation Information
12.6.2 Fluorochem Overview
12.6.3 Fluorochem N-Allylamine (CAS 589-09-3) Sales, Price, Revenue and Gross Margin (2016-2021)
12.6.4 Fluorochem N-Allylamine (CAS 589-09-3) Product Description
12.6.5 Fluorochem Recent Developments
12.7 3B Scientific Corporation
12.7.1 3B Scientific Corporation Corporation Information
12.7.2 3B Scientific Corporation Overview
12.7.3 3B Scientific Corporation N-Allylamine (CAS 589-09-3) Sales, Price, Revenue and Gross Margin (2016-2021)
12.7.4 3B Scientific Corporation N-Allylamine (CAS 589-09-3) Product Description
12.7.5 3B Scientific Corporation Recent Developments
12.8 Leancare Ltd
12.8.1 Leancare Ltd Corporation Information
12.8.2 Leancare Ltd Overview
12.8.3 Leancare Ltd N-Allylamine (CAS 589-09-3) Sales, Price, Revenue and Gross Margin (2016-2021)
12.8.4 Leancare Ltd N-Allylamine (CAS 589-09-3) Product Description
12.8.5 Leancare Ltd Recent Developments
12.9 Hubei Xinrunde Chemical Co., Ltd.
12.9.1 Hubei Xinrunde Chemical Co., Ltd. Corporation Information
12.9.2 Hubei Xinrunde Chemical Co., Ltd. Overview
12.9.3 Hubei Xinrunde Chemical Co., Ltd. N-Allylamine (CAS 589-09-3) Sales, Price, Revenue and Gross Margin (2016-2021)
12.9.4 Hubei Xinrunde Chemical Co., Ltd. N-Allylamine (CAS 589-09-3) Product Description
12.9.5 Hubei Xinrunde Chemical Co., Ltd. Recent Developments
12.10 Hubei Shishun Biological Technology Co., Ltd.
12.10.1 Hubei Shishun Biological Technology Co., Ltd. Corporation Information
12.10.2 Hubei Shishun Biological Technology Co., Ltd. Overview
12.10.3 Hubei Shishun Biological Technology Co., Ltd. N-Allylamine (CAS 589-09-3) Sales, Price, Revenue and Gross Margin (2016-2021)
12.10.4 Hubei Shishun Biological Technology Co., Ltd. N-Allylamine (CAS 589-09-3) Product Description
12.10.5 Hubei Shishun Biological Technology Co., Ltd. Recent Developments

13 Industry Chain and Sales Channels Analysis
13.1 N-Allylamine (CAS 589-09-3) Industry Chain Analysis
13.2 N-Allylamine (CAS 589-09-3) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 N-Allylamine (CAS 589-09-3) Production Mode & Process
13.4 N-Allylamine (CAS 589-09-3) Sales and Marketing
13.4.1 N-Allylamine (CAS 589-09-3) Sales Channels
13.4.2 N-Allylamine (CAS 589-09-3) Distributors
13.5 N-Allylamine (CAS 589-09-3) Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 N-Allylamine (CAS 589-09-3) Industry Trends
14.2 N-Allylamine (CAS 589-09-3) Market Drivers
14.3 N-Allylamine (CAS 589-09-3) Market Challenges
14.4 N-Allylamine (CAS 589-09-3) Market Restraints

15 Key Finding in The Global N-Allylamine (CAS 589-09-3) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global N-Allylamine (CAS 589-09-3) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of ≥99%
Table 3. Major Manufacturers of ≥98%
Table 4. Major Manufacturers of ≥95%
Table 5. Global N-Allylamine (CAS 589-09-3) Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 6. Global N-Allylamine (CAS 589-09-3) Production by Region: 2016 VS 2021 VS 2027 (Kiloton)
Table 7. Global N-Allylamine (CAS 589-09-3) Production by Region (2016-2021) & (Kiloton)
Table 8. Global N-Allylamine (CAS 589-09-3) Production Market Share by Region (2016-2021)
Table 9. Global N-Allylamine (CAS 589-09-3) Production by Region (2022-2027) & (Kiloton)
Table 10. Global N-Allylamine (CAS 589-09-3) Production Market Share by Region (2022-2027)
Table 11. Global N-Allylamine (CAS 589-09-3) Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 12. Global N-Allylamine (CAS 589-09-3) Sales by Region (2016-2021) & (Kiloton)
Table 13. Global N-Allylamine (CAS 589-09-3) Sales Market Share by Region (2016-2021)
Table 14. Global N-Allylamine (CAS 589-09-3) Sales by Region (2022-2027) & (Kiloton)
Table 15. Global N-Allylamine (CAS 589-09-3) Sales Market Share by Region (2022-2027)
Table 16. Global N-Allylamine (CAS 589-09-3) Revenue by Region (2016-2021) & (US$ Million)
Table 17. Global N-Allylamine (CAS 589-09-3) Revenue Market Share by Region (2016-2021)
Table 18. Global N-Allylamine (CAS 589-09-3) Revenue by Region (2022-2027) & (US$ Million)
Table 19. Global N-Allylamine (CAS 589-09-3) Revenue Market Share by Region (2022-2027)
Table 20. Global N-Allylamine (CAS 589-09-3) Production Capacity by Manufacturers (2016-2021) & (Kiloton)
Table 21. Global N-Allylamine (CAS 589-09-3) Capacity Market Share by Manufacturers (2016-2021)
Table 22. Global N-Allylamine (CAS 589-09-3) Production by Manufacturers (2016-2021) & (Kiloton)
Table 23. Global N-Allylamine (CAS 589-09-3) Production Market Share by Manufacturers (2016-2021)
Table 24. Global N-Allylamine (CAS 589-09-3) Sales by Manufacturers (2016-2021) & (Kiloton)
Table 25. Global N-Allylamine (CAS 589-09-3) Sales Share by Manufacturers (2016-2021)
Table 26. Global N-Allylamine (CAS 589-09-3) Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 27. Global N-Allylamine (CAS 589-09-3) Revenue Share by Manufacturers (2016-2021)
Table 28. N-Allylamine (CAS 589-09-3) Price by Manufacturers 2016-2021 (US$/Ton)
Table 29. Global N-Allylamine (CAS 589-09-3) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global N-Allylamine (CAS 589-09-3) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in N-Allylamine (CAS 589-09-3) as of 2020)
Table 31. N-Allylamine (CAS 589-09-3) Manufacturing Base Distribution and Headquarters
Table 32. Manufacturers N-Allylamine (CAS 589-09-3) Product Offered
Table 33. Date of Manufacturers Enter into N-Allylamine (CAS 589-09-3) Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global N-Allylamine (CAS 589-09-3) Sales by Type (2016-2021) & (Kiloton)
Table 36. Global N-Allylamine (CAS 589-09-3) Sales by Type (2022-2027) & (Kiloton)
Table 37. Global N-Allylamine (CAS 589-09-3) Sales Share by Type (2016-2021)
Table 38. Global N-Allylamine (CAS 589-09-3) Sales Share by Type (2022-2027)
Table 39. Global N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2021) & (US$ Million)
Table 40. Global N-Allylamine (CAS 589-09-3) Revenue by Type (2022-2027) & (US$ Million)
Table 41. Global N-Allylamine (CAS 589-09-3) Revenue Share by Type (2016-2021)
Table 42. Global N-Allylamine (CAS 589-09-3) Revenue Share by Type (2022-2027)
Table 43. N-Allylamine (CAS 589-09-3) Price by Type (2016-2021) & (US$/Ton)
Table 44. Global N-Allylamine (CAS 589-09-3) Price Forecast by Type (2022-2027) & (US$/Ton)
Table 45. Global N-Allylamine (CAS 589-09-3) Sales by Application (2016-2021) & (Kiloton)
Table 46. Global N-Allylamine (CAS 589-09-3) Sales by Application (2022-2027) & (Kiloton)
Table 47. Global N-Allylamine (CAS 589-09-3) Sales Share by Application (2016-2021)
Table 48. Global N-Allylamine (CAS 589-09-3) Sales Share by Application (2022-2027)
Table 49. Global N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2021) & (US$ Million)
Table 50. Global N-Allylamine (CAS 589-09-3) Revenue by Application (2022-2027) & (US$ Million)
Table 51. Global N-Allylamine (CAS 589-09-3) Revenue Share by Application (2016-2021)
Table 52. Global N-Allylamine (CAS 589-09-3) Revenue Share by Application (2022-2027)
Table 53. N-Allylamine (CAS 589-09-3) Price by Application (2016-2021) & (US$/Ton)
Table 54. Global N-Allylamine (CAS 589-09-3) Price Forecast by Application (2022-2027) & (US$/Ton)
Table 55. North America N-Allylamine (CAS 589-09-3) Sales by Type (2016-2021) & (Kiloton)
Table 56. North America N-Allylamine (CAS 589-09-3) Sales by Type (2022-2027) & (Kiloton)
Table 57. North America N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2021) & (US$ Million)
Table 58. North America N-Allylamine (CAS 589-09-3) Revenue by Type (2022-2027) & (US$ Million)
Table 59. North America N-Allylamine (CAS 589-09-3) Sales by Application (2016-2021) & (Kiloton)
Table 60. North America N-Allylamine (CAS 589-09-3) Sales by Application (2022-2027) & (Kiloton)
Table 61. North America N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2021) & (US$ Million)
Table 62. North America N-Allylamine (CAS 589-09-3) Revenue by Application (2022-2027) & (US$ Million)
Table 63. North America N-Allylamine (CAS 589-09-3) Sales by Country (2016-2021) & (Kiloton)
Table 64. North America N-Allylamine (CAS 589-09-3) Sales by Country (2022-2027) & (Kiloton)
Table 65. North America N-Allylamine (CAS 589-09-3) Revenue by Country (2016-2021) & (US$ Million)
Table 66. North America N-Allylamine (CAS 589-09-3) Revenue by Country (2022-2027) & (US$ Million)
Table 67. Europe N-Allylamine (CAS 589-09-3) Sales by Type (2016-2021) & (Kiloton)
Table 68. Europe N-Allylamine (CAS 589-09-3) Sales by Type (2022-2027) & (Kiloton)
Table 69. Europe N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2021) & (US$ Million)
Table 70. Europe N-Allylamine (CAS 589-09-3) Revenue by Type (2022-2027) & (US$ Million)
Table 71. Europe N-Allylamine (CAS 589-09-3) Sales by Application (2016-2021) & (Kiloton)
Table 72. Europe N-Allylamine (CAS 589-09-3) Sales by Application (2022-2027) & (Kiloton)
Table 73. Europe N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2021) & (US$ Million)
Table 74. Europe N-Allylamine (CAS 589-09-3) Revenue by Application (2022-2027) & (US$ Million)
Table 75. Europe N-Allylamine (CAS 589-09-3) Sales by Country (2016-2021) & (Kiloton)
Table 76. Europe N-Allylamine (CAS 589-09-3) Sales by Country (2022-2027) & (Kiloton)
Table 77. Europe N-Allylamine (CAS 589-09-3) Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe N-Allylamine (CAS 589-09-3) Revenue by Country (2022-2027) & (US$ Million)
Table 79. Asia Pacific N-Allylamine (CAS 589-09-3) Sales by Type (2016-2021) & (Kiloton)
Table 80. Asia Pacific N-Allylamine (CAS 589-09-3) Sales by Type (2022-2027) & (Kiloton)
Table 81. Asia Pacific N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2021) & (US$ Million)
Table 82. Asia Pacific N-Allylamine (CAS 589-09-3) Revenue by Type (2022-2027) & (US$ Million)
Table 83. Asia Pacific N-Allylamine (CAS 589-09-3) Sales by Application (2016-2021) & (Kiloton)
Table 84. Asia Pacific N-Allylamine (CAS 589-09-3) Sales by Application (2022-2027) & (Kiloton)
Table 85. Asia Pacific N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2021) & (US$ Million)
Table 86. Asia Pacific N-Allylamine (CAS 589-09-3) Revenue by Application (2022-2027) & (US$ Million)
Table 87. Asia Pacific N-Allylamine (CAS 589-09-3) Sales by Region (2016-2021) & (Kiloton)
Table 88. Asia Pacific N-Allylamine (CAS 589-09-3) Sales by Region (2022-2027) & (Kiloton)
Table 89. Asia Pacific N-Allylamine (CAS 589-09-3) Revenue by Region (2016-2021) & (US$ Million)
Table 90. Asia Pacific N-Allylamine (CAS 589-09-3) Revenue by Region (2022-2027) & (US$ Million)
Table 91. Latin America N-Allylamine (CAS 589-09-3) Sales by Type (2016-2021) & (Kiloton)
Table 92. Latin America N-Allylamine (CAS 589-09-3) Sales by Type (2022-2027) & (Kiloton)
Table 93. Latin America N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2021) & (US$ Million)
Table 94. Latin America N-Allylamine (CAS 589-09-3) Revenue by Type (2022-2027) & (US$ Million)
Table 95. Latin America N-Allylamine (CAS 589-09-3) Sales by Application (2016-2021) & (Kiloton)
Table 96. Latin America N-Allylamine (CAS 589-09-3) Sales by Application (2022-2027) & (Kiloton)
Table 97. Latin America N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2021) & (US$ Million)
Table 98. Latin America N-Allylamine (CAS 589-09-3) Revenue by Application (2022-2027) & (US$ Million)
Table 99. Latin America N-Allylamine (CAS 589-09-3) Sales by Country (2016-2021) & (Kiloton)
Table 100. Latin America N-Allylamine (CAS 589-09-3) Sales by Country (2022-2027) & (Kiloton)
Table 101. Latin America N-Allylamine (CAS 589-09-3) Revenue by Country (2016-2021) & (US$ Million)
Table 102. Latin America N-Allylamine (CAS 589-09-3) Revenue by Country (2022-2027) & (US$ Million)
Table 103. Middle East and Africa N-Allylamine (CAS 589-09-3) Sales by Type (2016-2021) & (Kiloton)
Table 104. Middle East and Africa N-Allylamine (CAS 589-09-3) Sales by Type (2022-2027) & (Kiloton)
Table 105. Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue by Type (2016-2021) & (US$ Million)
Table 106. Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue by Type (2022-2027) & (US$ Million)
Table 107. Middle East and Africa N-Allylamine (CAS 589-09-3) Sales by Application (2016-2021) & (Kiloton)
Table 108. Middle East and Africa N-Allylamine (CAS 589-09-3) Sales by Application (2022-2027) & (Kiloton)
Table 109. Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue by Application (2016-2021) & (US$ Million)
Table 110. Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue by Application (2022-2027) & (US$ Million)
Table 111. Middle East and Africa N-Allylamine (CAS 589-09-3) Sales by Country (2016-2021) & (Kiloton)
Table 112. Middle East and Africa N-Allylamine (CAS 589-09-3) Sales by Country (2022-2027) & (Kiloton)
Table 113. Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue by Country (2016-2021) & (US$ Million)
Table 114. Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue by Country (2022-2027) & (US$ Million)
Table 115. Ningbo Jinlai Chemical Co., Ltd. Corporation Information
Table 116. Ningbo Jinlai Chemical Co., Ltd. Description and Major Businesses
Table 117. Ningbo Jinlai Chemical Co., Ltd. N-Allylamine (CAS 589-09-3) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 118. Ningbo Jinlai Chemical Co., Ltd. N-Allylamine (CAS 589-09-3) Product
Table 119. Ningbo Jinlai Chemical Co., Ltd. Recent Development
Table 120. TimTec Corporation Corporation Information
Table 121. TimTec Corporation Description and Major Businesses
Table 122. TimTec Corporation N-Allylamine (CAS 589-09-3) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 123. TimTec Corporation N-Allylamine (CAS 589-09-3) Product
Table 124. TimTec Corporation Recent Development
Table 125. Wuhan Fengyao Tonghui Chemical Products Co., Ltd. Corporation Information
Table 126. Wuhan Fengyao Tonghui Chemical Products Co., Ltd. Description and Major Businesses
Table 127. Wuhan Fengyao Tonghui Chemical Products Co., Ltd. N-Allylamine (CAS 589-09-3) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 128. Wuhan Fengyao Tonghui Chemical Products Co., Ltd. N-Allylamine (CAS 589-09-3) Product
Table 129. Wuhan Fengyao Tonghui Chemical Products Co., Ltd. Recent Development
Table 130. Boc Sciences Corporation Information
Table 131. Boc Sciences Description and Major Businesses
Table 132. Boc Sciences N-Allylamine (CAS 589-09-3) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 133. Boc Sciences N-Allylamine (CAS 589-09-3) Product
Table 134. Boc Sciences Recent Development
Table 135. City Chemical Corporation Information
Table 136. City Chemical Description and Major Businesses
Table 137. City Chemical N-Allylamine (CAS 589-09-3) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 138. City Chemical N-Allylamine (CAS 589-09-3) Product
Table 139. City Chemical Recent Development
Table 140. Fluorochem Corporation Information
Table 141. Fluorochem Description and Major Businesses
Table 142. Fluorochem N-Allylamine (CAS 589-09-3) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 143. Fluorochem N-Allylamine (CAS 589-09-3) Product
Table 144. Fluorochem Recent Development
Table 145. 3B Scientific Corporation Corporation Information
Table 146. 3B Scientific Corporation Description and Major Businesses
Table 147. 3B Scientific Corporation N-Allylamine (CAS 589-09-3) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 148. 3B Scientific Corporation N-Allylamine (CAS 589-09-3) Product
Table 149. 3B Scientific Corporation Recent Development
Table 150. Leancare Ltd Corporation Information
Table 151. Leancare Ltd Description and Major Businesses
Table 152. Leancare Ltd N-Allylamine (CAS 589-09-3) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 153. Leancare Ltd N-Allylamine (CAS 589-09-3) Product
Table 154. Leancare Ltd Recent Development
Table 155. Hubei Xinrunde Chemical Co., Ltd. Corporation Information
Table 156. Hubei Xinrunde Chemical Co., Ltd. Description and Major Businesses
Table 157. Hubei Xinrunde Chemical Co., Ltd. N-Allylamine (CAS 589-09-3) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 158. Hubei Xinrunde Chemical Co., Ltd. N-Allylamine (CAS 589-09-3) Product
Table 159. Hubei Xinrunde Chemical Co., Ltd. Recent Development
Table 160. Hubei Shishun Biological Technology Co., Ltd. Corporation Information
Table 161. Hubei Shishun Biological Technology Co., Ltd. Description and Major Businesses
Table 162. Hubei Shishun Biological Technology Co., Ltd. N-Allylamine (CAS 589-09-3) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 163. Hubei Shishun Biological Technology Co., Ltd. N-Allylamine (CAS 589-09-3) Product
Table 164. Hubei Shishun Biological Technology Co., Ltd. Recent Development
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. N-Allylamine (CAS 589-09-3) Distributors List
Table 168. N-Allylamine (CAS 589-09-3) Customers List
Table 169. N-Allylamine (CAS 589-09-3) Market Trends
Table 170. N-Allylamine (CAS 589-09-3) Market Drivers
Table 171. N-Allylamine (CAS 589-09-3) Market Challenges
Table 172. N-Allylamine (CAS 589-09-3) Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. N-Allylamine (CAS 589-09-3) Product Picture
Figure 2. Global N-Allylamine (CAS 589-09-3) Market Share by Type in 2020 & 2027
Figure 3. ≥99% Product Picture
Figure 4. ≥98% Product Picture
Figure 5. ≥95% Product Picture
Figure 6. Global N-Allylamine (CAS 589-09-3) Market Share by Application in 2020 & 2027
Figure 7. Medicine
Figure 8. Coating
Figure 9. Others
Figure 10. N-Allylamine (CAS 589-09-3) Report Years Considered
Figure 11. Global N-Allylamine (CAS 589-09-3) Capacity, Production and Utilization (2016-2027) & (Kiloton)
Figure 12. Global N-Allylamine (CAS 589-09-3) Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global N-Allylamine (CAS 589-09-3) Production Market Share by Region (2016-2021)
Figure 14. Global N-Allylamine (CAS 589-09-3) Production Market Share by Region (2022-2027)
Figure 15. N-Allylamine (CAS 589-09-3) Production Growth Rate in North America (2016-2027) & (Kiloton)
Figure 16. N-Allylamine (CAS 589-09-3) Production Growth Rate in Europe (2016-2027) & (Kiloton)
Figure 17. N-Allylamine (CAS 589-09-3) Production Growth Rate in China (2016-2027) & (Kiloton)
Figure 18. N-Allylamine (CAS 589-09-3) Production Growth Rate in Japan (2016-2027) & (Kiloton)
Figure 19. Global N-Allylamine (CAS 589-09-3) Sales 2016-2027 (Kiloton)
Figure 20. Global N-Allylamine (CAS 589-09-3) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 21. Global N-Allylamine (CAS 589-09-3) Revenue 2016-2027 (US$ Million)
Figure 22. Global N-Allylamine (CAS 589-09-3) Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 23. Global N-Allylamine (CAS 589-09-3) Sales Market Share by Region (2016-2021)
Figure 24. Global N-Allylamine (CAS 589-09-3) Sales Market Share by Region (2022-2027)
Figure 25. North America N-Allylamine (CAS 589-09-3) Sales YoY (2016-2027) & (Kiloton)
Figure 26. North America N-Allylamine (CAS 589-09-3) Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Europe N-Allylamine (CAS 589-09-3) Sales YoY (2016-2027) & (Kiloton)
Figure 28. Europe N-Allylamine (CAS 589-09-3) Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Asia-Pacific N-Allylamine (CAS 589-09-3) Sales YoY (2016-2027) & (Kiloton)
Figure 30. Asia-Pacific N-Allylamine (CAS 589-09-3) Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Latin America N-Allylamine (CAS 589-09-3) Sales YoY (2016-2027) & (Kiloton)
Figure 32. Latin America N-Allylamine (CAS 589-09-3) Revenue YoY (2016-2027) & (US$ Million)
Figure 33. Middle East & Africa N-Allylamine (CAS 589-09-3) Sales YoY (2016-2027) & (Kiloton)
Figure 34. Middle East & Africa N-Allylamine (CAS 589-09-3) Revenue YoY (2016-2027) & (US$ Million)
Figure 35. The Top 10 and Top 5 Players Market Share by N-Allylamine (CAS 589-09-3) Sales in 2020
Figure 36. The Top 10 and Top 5 Players Market Share by N-Allylamine (CAS 589-09-3) Revenue in 2020
Figure 37. N-Allylamine (CAS 589-09-3) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 38. Global N-Allylamine (CAS 589-09-3) Sales Market Share by Type (2016-2027)
Figure 39. Global N-Allylamine (CAS 589-09-3) Revenue Market Share by Type (2016-2027)
Figure 40. Global N-Allylamine (CAS 589-09-3) Sales Market Share by Application (2016-2027)
Figure 41. Global N-Allylamine (CAS 589-09-3) Revenue Market Share by Application (2016-2027)
Figure 42. North America N-Allylamine (CAS 589-09-3) Sales Market Share by Type (2016-2027)
Figure 43. North America N-Allylamine (CAS 589-09-3) Revenue Market Share by Type (2016-2027)
Figure 44. North America N-Allylamine (CAS 589-09-3) Sales Market Share by Application (2016-2027)
Figure 45. North America N-Allylamine (CAS 589-09-3) Revenue Market Share by Application (2016-2027)
Figure 46. North America N-Allylamine (CAS 589-09-3) Sales Share by Country (2016-2027)
Figure 47. North America N-Allylamine (CAS 589-09-3) Revenue Share by Country (2016-2027)
Figure 48. United States N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 49. Canada N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 50. Europe N-Allylamine (CAS 589-09-3) Sales Market Share by Type (2016-2027)
Figure 51. Europe N-Allylamine (CAS 589-09-3) Revenue Market Share by Type (2016-2027)
Figure 52. Europe N-Allylamine (CAS 589-09-3) Sales Market Share by Application (2016-2027)
Figure 53. Europe N-Allylamine (CAS 589-09-3) Revenue Market Share by Application (2016-2027)
Figure 54. Europe N-Allylamine (CAS 589-09-3) Sales Share by Country (2016-2027)
Figure 55. Europe N-Allylamine (CAS 589-09-3) Revenue Share by Country (2016-2027)
Figure 56. Germany N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 57. France N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 58. U.K. N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 59. Italy N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 60. Russia N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 61. Asia Pacific N-Allylamine (CAS 589-09-3) Sales Market Share by Type (2016-2027)
Figure 62. Asia Pacific N-Allylamine (CAS 589-09-3) Revenue Market Share by Type (2016-2027)
Figure 63. Asia Pacific N-Allylamine (CAS 589-09-3) Sales Market Share by Application (2016-2027)
Figure 64. Asia Pacific N-Allylamine (CAS 589-09-3) Revenue Market Share by Application (2016-2027)
Figure 65. Asia Pacific N-Allylamine (CAS 589-09-3) Sales Share by Region (2016-2027)
Figure 66. Asia Pacific N-Allylamine (CAS 589-09-3) Revenue Share by Region (2016-2027)
Figure 67. China N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 68. Japan N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 69. South Korea N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 70. India N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 71. Australia N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 72. China Taiwan N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 73. Indonesia N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 74. Thailand N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 75. Malaysia N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 76. Latin America N-Allylamine (CAS 589-09-3) Sales Market Share by Type (2016-2027)
Figure 77. Latin America N-Allylamine (CAS 589-09-3) Revenue Market Share by Type (2016-2027)
Figure 78. Latin America N-Allylamine (CAS 589-09-3) Sales Market Share by Application (2016-2027)
Figure 79. Latin America N-Allylamine (CAS 589-09-3) Revenue Market Share by Application (2016-2027)
Figure 80. Latin America N-Allylamine (CAS 589-09-3) Sales Share by Country (2016-2027)
Figure 81. Latin America N-Allylamine (CAS 589-09-3) Revenue Share by Country (2016-2027)
Figure 82. Mexico N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 83. Brazil N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 84. Argentina N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 85. Colombia N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 86. Middle East and Africa N-Allylamine (CAS 589-09-3) Sales Market Share by Type (2016-2027)
Figure 87. Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue Market Share by Type (2016-2027)
Figure 88. Middle East and Africa N-Allylamine (CAS 589-09-3) Sales Market Share by Application (2016-2027)
Figure 89. Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue Market Share by Application (2016-2027)
Figure 90. Middle East and Africa N-Allylamine (CAS 589-09-3) Sales Share by Country (2016-2027)
Figure 91. Middle East and Africa N-Allylamine (CAS 589-09-3) Revenue Share by Country (2016-2027)
Figure 92. Turkey N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 93. Saudi Arabia N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 94. UAE N-Allylamine (CAS 589-09-3) Revenue (2016-2027) & (US$ Million)
Figure 95. N-Allylamine (CAS 589-09-3) Value Chain
Figure 96. N-Allylamine (CAS 589-09-3) Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed

---